Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 36 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

22Total
Not Applicable (18)
P 1 (2)
P 2 (1)
P 3 (1)

Trial Status

Recruiting13
Completed6
Not Yet Recruiting6
Active Not Recruiting5
Unknown4
Enrolling By Invitation2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 6 completed trials

Clinical Trials (36)

Showing 20 of 20 trials
NCT06149650Active Not RecruitingPrimary

Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study

NCT07731997Not ApplicableNot Yet RecruitingPrimary

IVUS Guidance in BTK Interventions

NCT06311773Not ApplicableEnrolling By InvitationPrimary

Pivotal Trial of the Boomerang Catheter for pDVA

NCT07536373Phase 3RecruitingPrimary

Colchicine in Chronic Limb-Threatening Ischemia

NCT07270575Not Yet Recruiting

REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapopliteal Artery Disease in Patients With Chronic Limb-threatening Ischemia

NCT07270562Not Yet Recruiting

ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threatening ischEmia

NCT07672249Recruiting

Predictors of Major Adverse Limb Events After Endovascular Iliac Stenting: a Real-world Cohort Study

NCT06330493Not ApplicableRecruitingPrimary

AcoArt Litos PCB Below-the-knee Global Trial

NCT05313165Not ApplicableRecruiting

PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

NCT07352800Phase 2Recruiting

Safety of Antithrombotic Heparin Proteoglycan Mimetic APAC in Peripheral Arterial Occlusive Disease and Chronic Limb-threatening Ischemia

NCT07488637Not ApplicableNot Yet RecruitingPrimary

Woundsome Revascularization in Chronic Limb-Threatening Ischemia

NCT06656364Not ApplicableActive Not RecruitingPrimary

Esprit BTK Post-Approval Study

NCT07201168Not ApplicableCompletedPrimary

Structured Educational Program vs Standard Care in Pre-surgical Critical Limb Ischemia Patients

NCT06071429Not ApplicableRecruitingPrimary

Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease

NCT07340112Not Yet Recruiting

Expression of GLP1 Receptor on Peripheral Blood Mononuclear Cells in Advanced Peripheral Artery Disease: Paving the Way for GLP1R Agonists Treatment in Chronic Limb Threatening Ischemia

NCT07330635Not ApplicableRecruiting

Chronic Wounds and Blood Circulation Detection

NCT06879561Not ApplicableRecruitingPrimary

Pressure Wire Guidance for Infrapopliteal Artery Interventions

NCT06264843RecruitingPrimary

Peripheral Bypass Trial for Completion Control

NCT06416644Not ApplicableActive Not Recruiting

The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry)

NCT06263322Not ApplicableRecruiting

The ROAMM-EHR Study

Scroll to load more

Research Network

Activity Timeline